Skip to main content

People in the News: New Hires at ArcticZymes, IntegenX, GenturaDx, GeneThera


ArcticZymes has named Brent Spoth as business development manager for the Americas.

Spoth, who will work out of ArcticZymes' recently opened US office in Plymouth Meeting, Penn., joins ArcticZymes from Bioneer, where he served as an account manager. Spoth has also served as an account executive at Gemini Bio-Products; and as an account manager and field applications scientist for Promega. He holds a PhD in microbiology from the University of Virginia.

IntegenX said this week that it has appointed Bob Barrett as vice president of strategy and business development for human identity products.

Barrett will help drive the commercialization strategy for IntegenX's RapidHit 200 sample-to-profile human identification system. He joins IntegenX from Qiagen, where he served as vice president of global marketing for molecular diagnostics. Prior to this, he was vice president and general manager of the applied markets division at Applied Biosystems, now Life Technologies. Barrett has also served as vice president of global marketing at Roche Molecular Systems and as vice president of commercial operations at Chiron.

GenturaDx has named Michael Treble to its board of directors.

Treble is currently chairman and CEO of Axela. Formerly he was president of Ibis Biosciences, now part of Abbott. He has also served as president and CEO of NimbleGen, now part of Roche; and has held positions with Third Wave Technologies, Roche Diagnostics, and Abbott Diagnostics.

GeneThera said this week that it has appointed Tony Milici as interim president of Applied Genetics, a joint venture between Nutricion Avanzada and GeneThera.

Located in Monterrey, Mexico, Applied Genetics focuses on molecular testing for Johne's disease, a global and incurable disease of dairy cows, sheep, and goats caused by Mycobacterium paratuberculosis sub. Avium, or MAP. The company markets HerdCheck, a proprietary molecular diagnostic test for the disease based on the use of high-throughput robotics and real-time PCR.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.